Press Releases



All Releases
View Summary Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Feb 8, 2016
 
View Summary Sangamo BioSciences Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference
Feb 4, 2016
PDF 34.6 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Fourth Quarter And Full Year 2015 Conference Call And Webcast
Feb 2, 2016
PDF 34.9 KB Add to Briefcase
View Summary Sangamo BioSciences Highlights 2016 Catalysts at the 34th Annual J.P. Morgan Healthcare Conference
Jan 11, 2016
PDF 40.1 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference
Jan 5, 2016
PDF 34.7 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies
Dec 11, 2015
PDF 91.3 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Data At The 2015 American Society Of Hematology Meeting Highlighting ZFP Therapeutic® Programs For Hemophilia And Hemoglobinopathies
Dec 7, 2015
PDF 41.3 KB Add to Briefcase
View Summary Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Dec 1, 2015
PDF 49.0 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2015 Piper Jaffray Healthcare Conference
Nov 23, 2015
PDF 43.2 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The Jefferies Autumn 2015 Global Healthcare Conference
Nov 11, 2015
PDF 42.8 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Publication Of Improved Method For Efficient Targeted Integration In Hematopoietic Stem Cells And T-cells
Nov 9, 2015
PDF 47.5 KB Add to Briefcase
View Summary Sangamo BioSciences To Present Data From ZFP Therapeutic Programs At Annual Meeting Of The American Society Of Hematology
Nov 5, 2015
PDF 50.3 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Third Quarter 2015 Financial Results
Oct 28, 2015
PDF 53.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Third Quarter 2015 Conference Call and Webcast
Oct 21, 2015
PDF 42.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2015 Stem Cell Meeting On The Mesa
Sep 30, 2015
PDF 45.3 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Updated Clinical Data from ZFP Therapeutic® Program for HIV/AIDS at the 2015 Interscience Conference of Antimicrobial Agents and Chemotherapy
Sep 21, 2015
PDF 49.9 KB Add to Briefcase
View Summary Sangamo Announces Unanimous Recombinant DNA Advisory Committee (RAC) Approval Of ZFP Therapeutic Phase 1 Study Protocol For First In Vivo Genome Editing Application
Sep 10, 2015
PDF 46.2 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2015 Morgan Stanley Global Healthcare Conference
Sep 9, 2015
PDF 42.7 KB Add to Briefcase
View Summary Sangamo and Shire Restructure Collaboration to Accelerate Development of ZFP Therapeutics® for the Treatment of Hemophilia and Huntington's Disease
Sep 2, 2015
PDF 46.9 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Second Quarter 2015 Financial Results
Aug 5, 2015
PDF 54.1 KB Add to Briefcase
Showing 1-20 of 540 Page: 1 2 3 4 5 ... 27  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote

Ticker:
SGMO
Exchange:
NASDAQ
Price:
5.66
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on Feb 5, 2016

Shareholder Tools